doi: 10.1155/2023/9781753.
eCollection 2023.
Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
- PMID: 37502593
- PMCID: PMC10371707
- DOI: 10.1155/2023/9781753
Item in Clipboard
Retracted: The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
Dis Markers.
.
Abstract
[This retracts the article DOI: 10.1155/2022/2184867.].
Copyright © 2023 Disease Markers.
Retraction of
-
The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma.Dis Markers. 2022 Mar 27;2022:2184867. doi: 10.1155/2022/2184867. eCollection 2022. Dis Markers. 2022. Retraction in: Dis Markers. 2023 Jul 19;2023:9781753. doi: 10.1155/2023/9781753. PMID: 35386230 Free PMC article. Retracted.
Similar articles
-
The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma.Dis Markers. 2022 Mar 27;2022:2184867. doi: 10.1155/2022/2184867. eCollection 2022. Dis Markers. 2022. Retraction in: Dis Markers. 2023 Jul 19;2023:9781753. doi: 10.1155/2023/9781753. PMID: 35386230 Free PMC article. Retracted.
-
[Retracted] 14‑3‑3β exerts glioma‑promoting effects and is associated with malignant progression and poor prognosis in patients with glioma.Exp Ther Med. 2024 Jan 8;27(3):93. doi: 10.3892/etm.2024.12368. eCollection 2024 Mar. Exp Ther Med. 2024. PMID: 38313580 Free PMC article.
-
Increased CDCA2 Level Was Related to Poor Prognosis in Hepatocellular Carcinoma and Associated With Up-Regulation of Immune Checkpoints.Front Med (Lausanne). 2022 Mar 7;8:773724. doi: 10.3389/fmed.2021.773724. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35372372 Free PMC article.
-
Retracted: Knockdown of lncRNA HOXD-AS2 Improves the Prognosis of Glioma Patients by Inhibiting the Proliferation and Migration of Glioma Cells.Evid Based Complement Alternat Med. 2023 Jul 19;2023:9859158. doi: 10.1155/2023/9859158. eCollection 2023. Evid Based Complement Alternat Med. 2023. PMID: 37501828 Free PMC article.
-
Retracted: KLHDC8A Expression in Association with Macrophage Infiltration and Oxidative Stress Predicts Unfavorable Prognosis for Glioma.Oxid Med Cell Longev. 2023 Sep 27;2023:9856509. doi: 10.1155/2023/9856509. eCollection 2023. Oxid Med Cell Longev. 2023. PMID: 37810558 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
